- Home
- WHLR vs MYNZ Comparison
WHLR vs MYNZ Comparison
Compare WHLR & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- MYNZ
- Stock Information
- Founded
- WHLR 2011
- MYNZ 2021
- Country
- WHLR United States
- MYNZ Germany
- Employees
- WHLR N/A
- MYNZ 26
- Industry
- WHLR Real Estate Investment Trusts
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- MYNZ Health Care
- Exchange
- WHLR Nasdaq
- MYNZ Nasdaq
- Market Cap
- WHLR 4.8M
- MYNZ 5.1M
- IPO Year
- WHLR 2012
- MYNZ 2021
- Fundamental
- Price
- WHLR $3.33
- MYNZ $1.41
- Analyst Decision
- WHLR
- MYNZ Buy
- Analyst Count
- WHLR 0
- MYNZ 2
- Target Price
- WHLR N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- WHLR 46.2K
- MYNZ 209.7K
- Earning Date
- WHLR 08-12-2025
- MYNZ 08-12-2025
- Dividend Yield
- WHLR N/A
- MYNZ N/A
- EPS Growth
- WHLR N/A
- MYNZ N/A
- EPS
- WHLR N/A
- MYNZ N/A
- Revenue
- WHLR $102,793,000.00
- MYNZ $893,991.00
- Revenue This Year
- WHLR N/A
- MYNZ $26.06
- Revenue Next Year
- WHLR N/A
- MYNZ $4.97
- P/E Ratio
- WHLR N/A
- MYNZ N/A
- Revenue Growth
- WHLR 0.86
- MYNZ N/A
- 52 Week Low
- WHLR $3.27
- MYNZ $1.30
- 52 Week High
- WHLR $10,458.00
- MYNZ $18.63
- Technical
- Relative Strength Index (RSI)
- WHLR 30.07
- MYNZ 38.13
- Support Level
- WHLR $4.05
- MYNZ $1.30
- Resistance Level
- WHLR $4.49
- MYNZ $2.07
- Average True Range (ATR)
- WHLR 0.33
- MYNZ 0.19
- MACD
- WHLR -0.11
- MYNZ -0.05
- Stochastic Oscillator
- WHLR 6.50
- MYNZ 15.77
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.